innovation.org
Home | About Us | Site Map | Contact Us Search
Impact of Innovation Future of Innovation Stories of Innovation Inside Drug Discovery News Center Tools & Resources
Future of Innovation
New Medicines in Development
Personalized Medicine in Action
Partnership for Prescription Assistance
Sign Up for
our Newsletter:

Get our newsletter on the impact of new medicines and updates on what's new in innovation.

New Medicines in Development

Today, over 3,200 new medicines are in development. Many of these potential new medicines will fail in clinical trials, but some may represent tomorrow's new treatments. In total, it takes approximately 10 to 15 years to go through the drug discovery and clinical development process and bring a medicine to the market. The process is also costly—the average R&D investment for each new medicine is $1.2 billion, including the cost of failures.[i]

 

Read More About New Medicines In Development For:

 

Alzheimer's Disease

America's biopharmaceutical research companies are currently developing 73 potential new treatments and diagnostics for Alzheimer's disease, which affects more than 5 million Americans and their families. Read more

 

Arthritis

The are 198 medicines currently in development to help the more than 50 million Americans afflicted with at least one of the 100 different musculoskeletal disorders. Read more

 

Asthma

America's biopharmaceutical research companies are developing 74 medicines to treat asthma, which affects more than 24 million American adults and children. Read more

 

Biologic Medicines

America’s biopharmaceutical research companies are testing a record 907 new medicines and vaccines that are derived through biotechnology. Read more

 

Cancer
There are 981 medicines and vaccines in development to treat patients with cancer. These treatments include 121 for lung cancer and 119 for breast cancer. Read more

 

Children

America’s pharmaceutical research and biotechnology companies are developing 282 medicines for the special health care needs of children. Read more

 

Chronic Diseases Affecting Older Americans

There are currently 465 medicines in development by America's biopharmaceutical companies to target the 10 leading chronic conditions affecting older Americans. Read more

 

Chronic Obstructive Pulmonary Disease (COPD)

There are currently more than 50 medicines in development for COPD, a disease that affects more than 13 million American adults and remains the third leading cause of death in the United States. Read more

 

Diabetes

There are currently 221 medicines in development by America's biopharmaceutical companies to treat diabetes. Read more

 

Heart Disease and Stroke
More than 200 potential medicines to treat heart disease and stroke are in the research pipeline. Read more

 

HIV/AIDS
Pharmaceutical researchers are testing nearly 75 medicines and vaccines to treat or prevent HIV/AIDS. Read more

 

Infectious Diseases

America's biopharmaceutical research companies are developing 394 new medicines to combat infectious diseases, including viral infections, bacterial infections, fungal infections and parasitic infections. Read more

 

Leukemia and Lymphoma

Each year nearly 150,000 Americans are diagnosed with a blood cancer—accounting for about 9 percent of all new cancer diagnoses. With 241 medicines in development by America's biopharmaceutical companies to target leukemia, lymphoma, myeloma and other cancers of the blood, there is great hope for patients diagnosed with these diseases. Read more

 

Mental Illnesses

There are 187 innovative medicines in development to treat patients with mental illnesses. These treatments include 52 for depression, 37 for schizophrenia and 26 for anxiety disorders. Read more

 

Neurological Disorders

America’s biopharmaceutical research companies are developing 444 medicines to prevent and treat neurological disorders including epilepsy, multiple sclerosis, Alzheimer’s disease, and Parkinson’s disease. Read more

 

Rare Diseases

There are more than 450 medicines currently in development to treat or prevent hundreds of rare diseases. Read more

 

Skin Diseases

There are currently 277 medicines in development to help the more than 100 million Americans, one third of the U.S. population, that suffer from at least one skin disease. Read more

 

Vaccines

America's biopharmaceutical research companies are currently developing more than 270 vaccines to prevent and treat disease. Read more

 

Women
Currently, there are 851 medicines in development for diseases that disproportionately or only affect women. Read more

 

 


 

[i] J.A. DiMasi and H.G. Grabowski, “The Cost of Biopharmaceutical R&D: Is Biotech Different?” Managerial and Decision Economics 28 (2007): 469–479.